(Image: Getty/Radachynskyi)

Recro spins out Baudax to boost CDMO focus

By Vassia Barba

Recro Pharma announces the separation of its acute care business to launch Baudax Bio as a developer of products, including non-opioid analgesics, to concentrate on its CDMO business.

CROs Face Stagnant Preclinical Market Growth

CROs Face Stagnant Preclinical Market Growth

By Zachary Brennan

An uptick in the outsourcing of preclinical trials is expected as pharmaceutical companies look to restructure and cut costs, but that increase won't necessarily begin in 2013, according to an analyst.


Follow us


View more


Featured Suppliers

All suppliers